Galmed Pharma (GLMD) Earnings
|
Expand Research on GLMD
| Next EPS Date | 8/14/26 *Est. | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +13.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -10.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/1/26  |
Q126 | N/A | -$0.51 | N/A | N/A | $1.3M | N/A | N/A | N/A | ||
| 11/19/25 |
Q325 | N/A | -$0.79 | N/A | N/A | $1.37M | N/A | N/A | N/A | ||
| 11/17/25 |
Q325 | N/A | -$0.79 | N/A | N/A | $1.37M | N/A | N/A | N/A | ||
| 11/13/25 |
Q325 | N/A | -$0.79 | N/A | N/A | $1.37M | N/A | N/A | N/A | ||
| 11/11/25 |
Q325 | N/A | -$0.79 | N/A | N/A | $1.37M | N/A | N/A | N/A | ||
| 11/10/25 |
Q325 | N/A | -$0.79 | N/A | N/A | $1.37M | N/A | N/A | N/A | ||
| 11/24/25 |
Q325 | N/A | -$0.79 | N/A | N/A | $1.37M | N/A | N/A | N/A | ||
| 8/14/25 |
Q225 | N/A | -$0.83 | N/A | N/A | $1.45M | N/A | N/A | N/A |
